FDA warns of Provigil risks

The FDA slapped a new warning on Provigil, a drug for narcolepsy and other sleeping disorders made by Cephalon. The agency warned doctors of sensitivity reactions--including rare but potentially deadly Stevens-Johnson syndrome--and of psychiatric side effects like hallucination and suicidal thoughts.

Provigil is also approved for use against drowsiness in shift worker--and it's been used off-label by truckers, med students and other types who want to stay awake all night, or even two to three days at a time. One of its selling points? Few side effects.

- read the new warning from the FDA
- see this story from the Houston Chronicle
- read about off-label use in Wired

Suggested Articles

At one point, Novartis even offered up $90 apiece for the inclisiran developer but would later say even $85 was too much, a securities filing shows.

Sanofi spent months hyping its Tuesday investor event, and new CEO Paul Hudson certainly laid out a different vision for the drugmaker at the confab.

After more than 10 years as partners, Sanofi and Regeneron are splitting up their deal to comarket PCSK9 med Praluent and immunology drug Kevzara.